HYDRALYTE_1170x120

prescription drug pricing issues

PCMA makes statement on congressional committee hearings on drug prices 

PCMA makes statement on congressional committee hearings on drug prices 

(Washington, D.C.) — As several congressional committees today examine prescription drug pricing issues Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott released the following statement: “We applaud the Senate Aging Committee, the House Ways and Means Subcommittee on Health, and the House Judiciary Subcommittee on Antitrust, Commercial, and Administrative Law for holding today’s